These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparative study of the effectiveness of zuclopenthixol acetate and haloperidol in acutely disturbed psychotic patients. Taymeeyapradit U; Kuasirikul S J Med Assoc Thai; 2002 Dec; 85(12):1301-8. PubMed ID: 12678168 [TBL] [Abstract][Full Text] [Related]
8. The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial. Goff DC; Arana GW; Greenblatt DJ; Dupont R; Ornsteen M; Harmatz JS; Shader RI J Clin Psychopharmacol; 1991 Apr; 11(2):106-12. PubMed ID: 2056136 [TBL] [Abstract][Full Text] [Related]
9. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects. Mazure CM; Nelson JC; Jatlow PI; Kincare P; Bowers MB J Clin Psychiatry; 1990 Aug; 51(8):330-4. PubMed ID: 2199431 [TBL] [Abstract][Full Text] [Related]
10. Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo. Balant LP; Balant-Gorgia AE; Eisele R; Reith B; Gex-Fabry M; Garrone G Pharmacopsychiatry; 1989 Nov; 22(6):250-4. PubMed ID: 2575763 [TBL] [Abstract][Full Text] [Related]
11. Plasma catecholamine metabolites and early response to haloperidol. Bowers MB; Swigar ME; Jatlow PI; Goicoechea N J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216 [TBL] [Abstract][Full Text] [Related]
12. Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity? Shostak M; Perel JM; Stiller RL; Wyman W; Curran S J Clin Psychopharmacol; 1987 Dec; 7(6):394-400. PubMed ID: 3429700 [TBL] [Abstract][Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
14. Ratio of serum prolactin to haloperidol and early clinical outcome in acute psychosis. Swigar ME; Jatlow PI; Goicoechea N; Opsahl C; Bowers MB Am J Psychiatry; 1984 Oct; 141(10):1281-3. PubMed ID: 6486269 [TBL] [Abstract][Full Text] [Related]
15. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol. Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; CarriĆ³ I; Alvarez E Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950 [TBL] [Abstract][Full Text] [Related]
16. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Bieniek SA; Ownby RL; Penalver A; Dominguez RA Pharmacotherapy; 1998; 18(1):57-62. PubMed ID: 9469682 [TBL] [Abstract][Full Text] [Related]
17. Correlates of early neuroleptic response using a uniform haloperidol dose. Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ; Goicoechea N Int Clin Psychopharmacol; 1987 Jul; 2(3):255-60. PubMed ID: 3693868 [TBL] [Abstract][Full Text] [Related]
18. Assessment of extrapyramidal symptoms during acute neuroleptic treatment. Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736 [TBL] [Abstract][Full Text] [Related]
19. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346 [TBL] [Abstract][Full Text] [Related]
20. Low dose oral haloperidol and blood levels in Alzheimer's disease: a preliminary study. Devanand DP; Cooper T; Sackeim HA; Taurke E; Mayeux R Psychopharmacol Bull; 1992; 28(2):169-73. PubMed ID: 1513920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]